Holistic Supportive Care in Oral Cancer: Principles and Practice

  • Nandini VallathEmail author
  • Naveen Salins


Life turns turbulent with the onset of cancer. The journey is physically and emotionally draining. From the shock of diagnosis through the ups and downs of treatment, the interminable tests and procedures, the pangs and ambiguity of remission, the recurrence or advancement, the progression of one alarming symptom after another and the unwelcome reality of unresponsiveness to treatment, each demands the utmost in human endurance. Health professionals are often the only sources of trust, clarity and guidance that patients and family have. It is our prerogative to recognise and empathise with the suffering of patients, physical or otherwise, and be effective in our roles.


  1. 1.
    Morrison RS, Meier DE. Palliative care. N Engl J Med. 2004;350:2582–90.PubMedCrossRefGoogle Scholar
  2. 2.
    Temel JS, Greer JA. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733.PubMedCrossRefGoogle Scholar
  3. 3.
    Murphy BA, Gilbert J. Oral cancerse: supportive care issues. Periodontol 2000. 2011;57:118–31.PubMedCrossRefGoogle Scholar
  4. 4.
    Kamstra JI, Jager H. Oral symptoms and functional outcome related to oral and oropharyngeal cancer. Support Care Cancer. 2011; 19:1327–1333, 201119:1327–33.PubMedCrossRefGoogle Scholar
  5. 5.
    Pusic A, Liu JC, Chen CM. A systematic review of patient-reported outcome measures in head and neck cancer surgery. Otolaryngol Head Neck Surg. 2007;136:525–35.PubMedCrossRefGoogle Scholar
  6. 6.
    A study to evaluate nurse-led on-treatment review for patients undergoing radiotherapy for head and neck cancer. J Clin Nurs, 2008;17:1428–39.Google Scholar
  7. 7.
    Kagan SH. The influence of nursing in head and neck cancer management. Curr Opin Oncol. 2009;21:248–53.PubMedCrossRefGoogle Scholar
  8. 8.
    Calman KC. Quality of life in cancer patients-an hypothesis. J Med Ethics. 1984;10:124–7.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Pastrana T, Vallath N, Mastrojohn J. Disparities in the contribution of low and middle-income countries to palliative care research. J Pain Symptom Manag. 2010;39(1):54–68.CrossRefGoogle Scholar
  10. 10.
    Penner JL, McClement SE. Using phenomenology to examine the experiences of family caregivers of patients with advanced head and neck cancer: reflections of a novice researcher. Int J Qual Methods. 2008;7:92–101.CrossRefGoogle Scholar
  11. 11.
    Accountable care organisations. New Engl J Med. 2011;e4(1).  10.1056/nejm1112293.
  12. 12.
    Elad S, Raber-Durlacher JE, Brennan MT, et al. Basic oral care for hematology–oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer. 2015;23(1):223–36. doi: 10.1007/s00520–014-2378-x.PubMedCrossRefGoogle Scholar
  13. 13.
    Shorthose K, Davies AN. Symptom prevalence in palliative care. Palliat Med. 2003;17:73–4.CrossRefGoogle Scholar
  14. 14.
    Chalmers JM, King PL, et al. The oral health assessment tool – validity and reliability. Aust Dent J. 2005;50(3):191–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7:6–9.PubMedGoogle Scholar
  16. 16.
    Dios PD, Lestón JS. Oral cancer pain. Oral Oncol. 2010;46(6):448–51.PubMedCrossRefGoogle Scholar
  17. 17.
    Cuffari L, Tesseroli T, Nemr K. Pain complaint as the first symptom of oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:56–61.PubMedCrossRefGoogle Scholar
  18. 18.
    Epstein JB, Elad S, Eliav E, Jurevic R, Benoliel R. Orofacial pain in cancer: part II clinical perspectives and management. J Dent Res. 2007;86(6):506–18.PubMedCrossRefGoogle Scholar
  19. 19.
    Epstein JB, Hong C, Logan RM, et al. A systematic review of oro-facial pain in patients receiving cancer therapy. Support Care Cancer. 2010;18:1023.PubMedCrossRefGoogle Scholar
  20. 20.
    Benoliel R, Epstein J, Eliav E, Jurevic R, Elad S. Orofacial pain in cancer: part I – mechanisms. J Dent Res. 2007;86(6):491–505.PubMedCrossRefGoogle Scholar
  21. 21.
    Lam DK, Schmidt BL. Orofacial pain onset predicts transition to head and neck cancer. Pain. 2011;152(5):1206–9.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Kamstra JI, Jager-Wittenaar H, Dijkstra PU, Huisman PM, van Oort RP, van der Laan BF. Oral symptoms and functional outcome related to oral and oropharyngeal cancer. Support Care Cancer. 2011;19(9):1327–33.PubMedCrossRefGoogle Scholar
  23. 23.
    Scott-Warren J, Bhaskar A, et al. Cancer pain management. Contin Educ Anaesth Crit Care Pain. 2014;14(6):278–84.CrossRefGoogle Scholar
  24. 24.
    Dijkstra PU, Sterken MW. Exercise therapy for trismus in head and neck cancer. Oral Oncol. 2006;43:389–94.PubMedCrossRefGoogle Scholar
  25. 25.
    Cancer pain relief with a guide to opioid availability. 2nd ed. Geneva: World Health Organisation; 1996.Google Scholar
  26. 26.
    WHO. Principles of good chronic care. Geneva: WHO Publications. World Health; 2004.Google Scholar
  27. 27.
    Vallath N, Kumar M, Salins N. Unpleasant subjective emotional experiencing of pain (a review). Indian J Palliat Care. 2013;19(1):12–9.Google Scholar
  28. 28.
    Gellrich N-C, Schimming R, Schramm A, Schmalohr D, Bremerich A, Kugler J. Pain, function, and psychologic outcome before, during, and after intraoral tumour resection. J Oral Maxillofac Surg. 2002;60(7):772–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Saunders CM. The management of terminal malignant disease. 1st ed. London: Edward Arnold; 1978.Google Scholar
  30. 30.
    Olsen A-MS, Fosbol EL. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study. Circulation. 2011;123:2226–35.CrossRefGoogle Scholar
  31. 31.
    Fosbøl EL. Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals. Circulation. 2010;3:395–405.PubMedGoogle Scholar
  32. 32.
    Caraceni A, Hanks G r. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13:E 58–68.CrossRefGoogle Scholar
  33. 33.
    Ripamonti CI, Bandieri E, Roila F. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22:69–77.CrossRefGoogle Scholar
  34. 34.
    Klepstad P, Kaasa S, Borchgrevink PC. Starting step III opioids for moderate to severe pain in cancer patients: dose titration: a systematic. Palliat Med. 2011;25:424.PubMedCrossRefGoogle Scholar
  35. 35.
    Sureshkumar, Rajagopal MR. Intravenous morphine for emergency treatment of cancer pain. Palliat Med. 2000;14:183–8.CrossRefGoogle Scholar
  36. 36.
    Joranson DE, Rajagopal MR, Gilson AM. Improving access to opioid analgesics for palliative care in India. J Pain Symptom Manag. 2002;24(2):152–9.CrossRefGoogle Scholar
  37. 37.
    Rajagopal MR, Joranson DE, Gilson AM. Medical use, misuse, and diversion of opioids in India. Lancet. 2001;358(9276):139–43.PubMedCrossRefGoogle Scholar
  38. 38.
    Vallath N. Perspectives on yoga inputs in the management of chronic pain. Indian J Palliat Care. 2010;16(1):1–7.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Lobato RD. Intraventricular morphine for intractable cancer pain; rationale, methods, clinical results. Acta Anaesthesiol Scand. 1987;31:61–74.CrossRefGoogle Scholar
  40. 40.
    Davies A. Salivary gland dysfunction. In: Finlay I, Davies A, editors. oral care in advanced disease. Oxford: Oxford Unicersity Press; 2005.CrossRefGoogle Scholar
  41. 41.
    Kam MK, Leung SF, Zee B. Prospective randomized study of intensitymodulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007;25:4873–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Jha N, Seikaly H, Harris J. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia. Head Neck. 2009;31:234–43.PubMedCrossRefGoogle Scholar
  43. 43.
    Sasse AD, Clark LG. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. Int J Radiat Oncol Biol Phys. 2005;64:784–91.PubMedCrossRefGoogle Scholar
  44. 44.
    Rieke JW, Hafermann MD. Oral pilocarpine for radiation induces xerostomia: integrated safety and efficacy results from two prospective randomised clinical trials. Int J Radiat Oncol Biol Phys. 1995;31:661–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Johnstone PA, Niemtzow RC. Acupuncture for xerostomia. Cancer. 2002;94:1151–6.PubMedCrossRefGoogle Scholar
  46. 46.
    Leung KC, McMillan AS, Wong MC, et al. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren’s syndrome in southern Chinese patients:a randomised doubleblind, placebocontrolled crossover study. Clin Rheumatol. 2008;27:429.PubMedCrossRefGoogle Scholar
  47. 47.
    Gerlach NL, Barkhuysen R. The effect of hyperbaric oxygen therapy on quality of life in oral and oropharyngeal cancer patients treated with radiotherapy. Int J Oral Maxillofac Surg. 2008;37:255–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Deasy JO, Moiseenko V, Marks L, et al. Radiotherapy dosevolume effects on salivary gland function. Int Radiat Oncol Biol Phys. 2010;76:S 58.CrossRefGoogle Scholar
  49. 49.
    Sonis ST. A biological approach to mucositis. J Support Oncol. 2004;2:21–32.PubMedGoogle Scholar
  50. 50.
    Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients with cancer. Dent Clin N Am. 2008;52(1):61–viii.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Elting LS, Cooksley CD. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68:1110–20.PubMedCrossRefGoogle Scholar
  52. 52.
    Harris DJ, Eilers J. Putting evidence into practice, evidence-based interventions for the management of oral mucositis. Clin J Oncol Nurs. 2008;12(1):141–52.PubMedCrossRefGoogle Scholar
  53. 53.
    Liu C, Zhou Z, Liu G, Wang Q, et al. Efficacy and safety of dexamethasone ointment on recurrent aphthous ulceration. Am J Med. 2012;125(3):292–301. Mar 2012, Vol. 125. 292–301PubMedCrossRefGoogle Scholar
  54. 54.
    Negrin RS, Toljanic JA. Oral toxicity associated with chemotherapy. Up-to-date; 2014.Google Scholar
  55. 55.
    Sankar V, Hearnden V, Hull K, Juras DV, Greenberg MS, Kerr AR, et al. Local drug delivery for oral mucosal diseases: challenges and opportunities. Oral Dis. 2011;17(Suppl 1) (December 2010):73–84.PubMedCrossRefGoogle Scholar
  56. 56.
    Peterson DE. New strategies for management of oral mucositis in cancer patients. J Support Oncol. 2006;4(2 Suppl 1):9–13.PubMedGoogle Scholar
  57. 57.
    Lalla R, Bowen J, Keefe DM, the mucositis guidelines leadership group of MASCC/ISOO, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453–61.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Silverman S. Diagnosis and management of oral mucositis. J Support Oncol. 2007;5(1):013–21.Google Scholar
  59. 59.
    Finnerup NB, Jensen TS. Mechanisms of disease: mechanism based classification of neuropathic pain – a critical analysis. Nat Clin Pract Neurol. 2006;2:107–15.PubMedCrossRefGoogle Scholar
  60. 60.
    Ripamonti F, Fulfaro C. Taste alterations in cancer patients. J Pain Symptom Manag. 1998;16:349–51.CrossRefGoogle Scholar
  61. 61.
    Hovan AJ, Williams PM, Stevenson Moore P, et al. A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer. 2010;18:1081.PubMedCrossRefGoogle Scholar
  62. 62.
    Murphy BA, Gilbert J. Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae, and rehabilitation. Semin Radiat Oncol. 2009;19:35–42.PubMedCrossRefGoogle Scholar
  63. 63.
    Lazarus C, Logemann JA, Gibbons P. Effects of maneuvers on swallowing function in a dysphagic oral cancer patient. Head Neck. 1993;15:419.PubMedCrossRefGoogle Scholar
  64. 64.
    Clavé P, de Kraa M, Arreola V, et al. The effect of bolus viscosity on swallowing function in neurogenic dysphagia. Aliment Pharmacol Ther. 2006;24:1385.PubMedCrossRefGoogle Scholar
  65. 65.
    Laurell G, Kraepelien T. Stricture of the proximal esophagus in head and neck carcinoma patients after radiotherapy. Cancer. 2003;97:1693–700.PubMedCrossRefGoogle Scholar
  66. 66.
    Bensadoun R-J, Patton LL, Lalla RV, Epstein JB. Oropharyngeal candidiasis in head and neck cancer patients treated with radiation. Support Care Cancer. 2011;19(6):737–44.PubMedCrossRefGoogle Scholar
  67. 67.
    Mosel DD, Bauer RL, Lynch DP, Hwang ST. Oral complications in the treatment of cancer patients. Oral Dis. 2011;17(6):550–9.PubMedCrossRefGoogle Scholar
  68. 68.
    Deng Z, Kiyuna A, Hasegawa M, Nakasone I, Hosokawa A, Suzuki M. Oral candidiasis in patients receiving radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg. 2010;143(2):242–7.PubMedCrossRefGoogle Scholar
  69. 69.
    Wilberg P, Hjermstad MJ, Ottesen S, Herlofson BB. Oral health is an important issue in end-of-life cancer care. Support Care Cancer. 2012;21:3115–22.CrossRefGoogle Scholar
  70. 70.
    Worthington HV, Eden OB, Clarkson JE. Interventions for preventing oral candidiasis for patients with cancer receiving treatment. Cochrane Database Syst Rev. 2002;3:CD003807. Online, Vol 4.Google Scholar
  71. 71.
    Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503–35.PubMedCrossRefGoogle Scholar
  72. 72.
    Roodenburg J, Davies A. Head and neck cancer. In: Finlay I, Davies A, editors. Oral care in advanced disease. Oxford: Oxford University Press; 2005.Google Scholar
  73. 73.
    Evans WJ et al. Cachexia: a new definition. Clin Nutr. 2008;27:793–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Bruera E. ABC of palliative care: anorexia, cachexia, and nutrition. BMJ. 1997;315:1219–22.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    adbruch L, Elsner F, Trottenberg P. Clinical practice guidelines on cancer cachexia in advanced cancer patients with a focus on refractory cachexia. Eur Assoc Palliat Care. 2010.Google Scholar
  76. 76.
    Del Fabbro E, Dev R, Hui D, et al. Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double blind placebo controlled trial. J Clin Oncol. 2013;31:1271.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Riechelmann RP, Burman D, Tannock IF, et al. Phase II trial of mirtazapine for cancer related cachexia and anorexia. Am J Hosp Palliat Care. 2010;27:106.PubMedCrossRefGoogle Scholar
  78. 78.
    Navari RM, Brenner MC. Treatment of cancer related anorexia with olanzapine and megestrol acetate: a randomized trial. Support Care Cancer. 2010;18:951.PubMedCrossRefGoogle Scholar
  79. 79.
    Bruera E. Cancer-related fatigue: a multidimensional syndrome. J Support Oncol. 2010;8:175–6.Google Scholar
  80. 80.
    Yennurajalingam S, Bruera E. Palliative management of fatigue at the close of life: “It Feels Like My Body Is Just Worn Out”. JAMA. 2007;297(3):294–304.CrossRefGoogle Scholar
  81. 81.
    Segal RJ, Reid RD. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003;21:1653–9.PubMedCrossRefGoogle Scholar
  82. 82.
    Caraceni A, Simonetti F. Palliating delirium in patients with cancer. Lancet Oncol. 2009;10(2):164–72.PubMedCrossRefGoogle Scholar
  83. 83.
    Oldervoll LM, Loge JH. The effect of a physical exercise program in palliative care. J Pain Symptom Manag. 2006;31:421–30.CrossRefGoogle Scholar
  84. 84.
    Dhruva A, Miaskowski C, Abrams D, Acree M. Yoga breathing for cancer chemotherapy-associated symptoms and quality of life: results of a pilot randomized controlled trial. J Altern Complement Med. 2012;18(5):473–9.PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Bruera E. Cancer-related fatigue: a multidimensional syndrome. J Support Oncol. 2010;8(4):175–6.PubMedGoogle Scholar
  86. 86.
    Fang C-K, Chen H-W, Liu S-I, Lin C-J, Tsai L-Y, Lai Y-L. Prevalence, detection and treatment of delirium in terminal cancer inpatients: a prospective survey. Jpn J Clin Oncol. 2008;38(1):56–63.PubMedCrossRefGoogle Scholar
  87. 87.
    Lawlor PG, Gagnon B, Mancini IL, Pereira JL, Hanson J, Suarez-Almazor ME, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med. 2000;160(6):786–94.PubMedCrossRefGoogle Scholar
  88. 88.
    Centeno C, Montalvos HL, Bruera E. Delirium in advanced cancer patients. Med Paliat. 2004;18:184–95.CrossRefGoogle Scholar
  89. 89.
    Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941–8.PubMedCrossRefGoogle Scholar
  90. 90.
    Breitbart W, Rosenfeld B, Roth A. The memorial delirium rating scale. J Pain Symptom. 1997;13:128–37.CrossRefGoogle Scholar
  91. 91.
    Gurschick L, Mayer DK, Hanson LC. Palliative sedation: an analysis of international guidelines and position statements. Am J Hosp Palliat Care. 2015;32:660–71.Google Scholar
  92. 92.
    Cherni N, Radbruch L. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med. 2009;23(7):581–93.CrossRefGoogle Scholar
  93. 93.
    Inouye SK et al. The Hospital Elder Life Program: a model of care to prevent cognitive and functional decline in older hospitalized patients. Hospital Elder Life Program. J Am Geriatr Soc. 2000;48(12):1697–706.PubMedCrossRefGoogle Scholar
  94. 94.
    Garg C, Karan A. Reducing out-of-pocket expenditures to reduce poverty: a disaggregated analysis at rural, urban and state levels in India. Health Policy Plan. 2009;24:116–28.PubMedCrossRefGoogle Scholar
  95. 95.
    Nandini V, Sridhar CN, Usharani MR, Kumar JP, Salins N. Incorporating person centred care principles into an ongoing comprehensive cancer management program: an experiential account. Indian J Palliat Care. 2011;17:S 61–7.CrossRefGoogle Scholar
  96. 96.
    Hippocrates. Book of prognostics. 2004.Google Scholar
  97. 97.
    Stockler MR, Tattersall MH, Boyer MJ. Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer. Br J Cancer. 2006;94(2):208–12.PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Casarett D. The median is not the (only) message. Ann Intern Med. 2006;145(9):700–1.PubMedCrossRefGoogle Scholar
  99. 99.
    Hauser CA, Stockler MR, Tattersall MH. Prognostic factors in patients with recently diagnosed incurable cancer a systematic review. Support Care Cancer. 2006;14(10):999–1011.PubMedCrossRefGoogle Scholar
  100. 100.
    Nagaraj NS. Evolving ‘omics’ technologies for diagnostics of head and neck cancer. Oxf J Adv Access Publ Brief Funct Genomics Proteomics. Mar 2009;8(1):49–59.CrossRefGoogle Scholar
  101. 101.
    Dawes RM, Faust D. Clinical versus actuarial judgment. Science. 1989;243(4899):1668–74.PubMedCrossRefGoogle Scholar
  102. 102.
    Casarett D. The median is not the (only) message. Ann Intern Med. 2006;145(9):700–701.Google Scholar
  103. 103.
    Lunney JR. Patterns of functional decline at the end of life. JAMA. 2003;289(18):2387–92.PubMedCrossRefGoogle Scholar
  104. 104.
    Murray SA, Sheikh A. Care for all at the end of life. Br Med J. 2008;336:958–9.CrossRefGoogle Scholar
  105. 105.
    Satariano WA. Comorbidities and cancer. In: Johnson KA, Muss HB, Hunter CP. Cancer in the elderly. New York: Marcel Dekker; 2000.Google Scholar
  106. 106.
    Ma C, Bandukwala S, Burman D, Bryson J, Seccareccia D, Banerjee S, Myers J, Rodin G, Dudgeon D, Zimmermann C. Interconversion of three measures of performance status: an empirical analysis. Eur J Cancer. 2010;46:3175–83.PubMedCrossRefGoogle Scholar
  107. 107.
    Baijal G, Gupta T, Hotwani C, Lasker SG, Budrukkar A, Murthy V, Agarwal JP. Impact of comorbidity on therapeutic decision-making in head and neck cancer: audit from a comprehensive cancer center in India. Head Neck. 2012;34:1251–4.Google Scholar
  108. 108.
  109. 109.
    Daugherty CK. Examining ethical dilemmas as obstacles to hospice and palliative care for advanced cancer patients. Cancer Investig. 2004;22(1):123–31.CrossRefGoogle Scholar
  110. 110.
    Piccirillo JF, Tierney RM, Costas. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291(20):2441–7.PubMedCrossRefGoogle Scholar
  111. 111.
    Gourin CG, Boyce BJ, Vaught CC. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma. Laryngoscope. 2009;119(5):907–14. 2009, Vol. 119. 907–14PubMedCrossRefGoogle Scholar
  112. 112.
    Maltoni M, Scarpi E, Pittureri C, et al. Prospective comparison of prognostic scores in palliative care cancer populations. Oncologist. 2012;17(3):446–54. doi: 10.1634/theoncologist.2011-0397.PubMedPubMedCentralCrossRefGoogle Scholar
  113. 113.
    Phillips LS, Branch WT. Clinical inertia. Ann Intern Med. 2001;135(9):825–34.PubMedCrossRefGoogle Scholar
  114. 114.
    Kleinman Arthur. Caregiving: The odyssey of becoming more human. The Lancet 2009;373(9660):292–293.Google Scholar
  115. 115.
    Chandra PS, Chaturvedi SK. Awareness of diagnosis and psychiatric morbidity among cancer patients – a study from South India – knowledge and attitudes. J Psychosom Res. 1998;45:257–61.PubMedCrossRefGoogle Scholar
  116. 116.
    Archer J, Hutchison I, Korszun A. Mood and malignancy: head and neck cancer and depression. J Oral Pathol Med. 2008;37(5):255–70. Vol. 37. 255–70PubMedCrossRefGoogle Scholar
  117. 117.
    Vallath N. Perspectives on psychoneuroimmunology on oncology. Indian J Palliat Care. 2006;12:29–33.CrossRefGoogle Scholar
  118. 118.
    Schedlowski M, Kugler J, Schulz KH. How the brain and the immune system communicate with each other. In: Merz F, Riiter M, editors. Psychoneuroimmunology. Berlin: Pabst Science Publischers; 1994.Google Scholar
  119. 119.
    Turner JA, Holtzman S. Mediators, moderators, and predictors of therapeutic change in cognitive–behavioral therapy for chronic pain. Pain. 2007;127:276–86.PubMedCrossRefGoogle Scholar
  120. 120.
    Dusek JA. Association between oxygen production and nitrous oxideproduction during relaxation response. Med Sci Monit. 2006; 200612(1):1–10.Google Scholar
  121. 121.
    National Breast Cancer Centre and National Cancer Control. Clinical practice guidelines for the psychosocial of adults with cancer. Initiative. Camperdown: National Breast Cancer Centre; 2004.Google Scholar
  122. 122.
    Holland J, Greenberg D et al. Distress management. [Online] National Comprehensive Cancer Network, National Clinical Practice Guidelines in Oncology. 2010.
  123. 123.
    Chitra V, Manoj KT. Psycho-oncology in India: emerging trends from Kerala. Indian J Palliat Care. 2006;12(1):34–8.CrossRefGoogle Scholar
  124. 124.
    Walsh D. Palliative medicine. Philadelphia: Saunders Elsevier; 2009. p. 320.Google Scholar
  125. 125.
    Sharp L, Johansson H. Smoking cessation among patients with head and neck cancer: cancer as a ‘teachable moment. Eur J Cancer Care. 2008;17:114–9.CrossRefGoogle Scholar
  126. 126.
    Stelzle F, Knipfer C. Factors influencing relative speech intelligibility in patients with oral squamous cell carcinoma: a prospective study using automatic, computer-based speech analysis. Int J Oral Maxillofac Surg. 2013;42(11):1377–84.PubMedCrossRefGoogle Scholar
  127. 127.
    Kissane DW, Bylund CL. Communication skills training for oncology professionals. J Clin Oncol. 2012;30(11):1242–7.PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Slevin ML, Stubbs L, Plant HJ, et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. Br Med J. 1990;300:1458–60.CrossRefGoogle Scholar
  129. 129.
    Students, National Workshop for developing Palliative Care modules for undergraduate medical. curricula. [Online] 2014. [Cited: Feb 12, 2015].
  130. 130.
    Low JA et al. Reducing collusion between family members and clinicians of patients referred to the palliative care team. Permanente J. 2009;13(4):11–5.CrossRefGoogle Scholar
  131. 131.
    Chaturvedi SK, Loiselle CG, Chandra PS. Communicating with relatives and collusion in palliative care: cross cultural perspectives. Indian J Palliat Med. 2009;15(1):5–9.Google Scholar
  132. 132.
    Pennigton C. To PEG or not to PEG. Clin Med. 2002;2(3):250–4.CrossRefGoogle Scholar
  133. 133.
    Rabeneck L, McCullough LB, Wray NP. Ethically justified, clinically comprehensive guidelines for percutaneous endoscopic gastrostomy tube placement. Lancet. 1997;349:496–8.PubMedCrossRefGoogle Scholar
  134. 134.
    Friedrich L et al. End of life nutrition: is tube feeding the solution? Ann Longterm Care. 2013;21:30–3.Google Scholar
  135. 135.
    Jonsen A, Siegler M, Winslade W. Clinical ethics. J Legal Med. 1993;14(2):355–7.CrossRefGoogle Scholar
  136. 136.
    Bone RC. You and I are dying. In : Reflections; a guide to end of life issues for you and your family. Vol. 4(3). Published by National Kidney Cancer Association, Evanston IL, USA: J Endotoxin Research; 1997. pp. 235–6.Google Scholar
  137. 137.
    Mani RK, Amin P et al. Limiting life prolonging interventions and prolonging palliative care towards end of life in Indian Intensive Care Units. [Online] 2008.
  138. 138.
    Dikshit R, Gupta PC. Cancer mortality in India: a nationally representative survey. 2012.
  139. 139.
    Rao MJ. 196th report, Law Commission of India on medical treatment to terminally ill. 2006.Google Scholar
  140. 140.
    Myatra SN, Salins N, Iyer S, Macaden SC, Divatia JV, Muckaden M, Kulkarni P, Simha S, Mani RK. End-of-life care policy: an integrated care plan for the dying. Indian J Crit Care Med. 2014;18:615–35.PubMedPubMedCentralCrossRefGoogle Scholar
  141. 141.
    Curtis JR, White DB. Practical guidance for evidence-based ICU family conferences. Chest. 2008;134(4):835–43.Google Scholar
  142. 142.
    Glare PA, Sinclair CT. Palliative medicine review: prognostication. J Palliat Med. 2008;11(1):84–103.PubMedCrossRefGoogle Scholar
  143. 143.
    Kumar S. Learning from low income countries: what are the lessons? Palliative care can be delivered through neighbourhood networks. BMJ. 2004;329:1184.PubMedPubMedCentralCrossRefGoogle Scholar
  144. 144.
    Schaerer R. Suffering of the doctor linked with death of patients. Palliat Med. 1993;7:27–37.CrossRefGoogle Scholar
  145. 145.
    Kearney MK, Weininger RB, et al. Self-care of physicians caring for patients at the end of life-being connected. A key to my survival. JAMA. 2009;301(11):1155–64.Google Scholar
  146. 146.
    Cherny NI, Catane R, Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer: report on a survery by the European Society of Medical Oncology Taskforce on Palliative and Supportive Care. Cancer 2003;98:2502–10.Google Scholar
  147. 147.
    Davis MP. Determination of nutrition and hydration. In: Walsh D, editor. Palliative medicine. Philadelphia: Sauders Elsevier; 2009.Google Scholar
  148. 148.
    Mc Cann RM, Hall WJ. Comfort care for terminaly ill patients: the appropriate use of nutrition and hydration. JAMA. 1994;26:1263–6.Google Scholar
  149. 149.
    Lanuke K, Fainsinger RL. Hydration management in palliative care settings – a survey of experts. J Palliat Care. 2003;19:278–9.PubMedGoogle Scholar
  150. 150.
    Maltoni M. Ann Oncol. 2009;20:1163–9.PubMedCrossRefGoogle Scholar
  151. 151.
    Vachon MLS. The meaning of illness to a long term survivor. Semin Oncol Nurs. 2001;17:279–83.PubMedCrossRefGoogle Scholar
  152. 152.
    Education in palliative medicine. Biasco G. Kolkotta: 19th international conference, by the Indian Association of Palliative Medicine, 2012.Google Scholar
  153. 153.
    Jeremy Geffen MD. The journey through Cancer. New York: Crown Publishers; 2000. p. 13–4.Google Scholar
  154. 154.
    Caplan AL. Department of medical ethics and health policy. Medscape. 2012. University of Pennsylvani.Google Scholar

Suggested Reading Material and Websites

  1. Annals of Internal Medicine – Expert Panel report on using opioids for chronic pain
  2. CanSupport –
  3. Education in Palliative and End-of-life Care [EPEC] –
  4. From Doctor to Healer – The transformative Journey by Robbie Davis Floyd and Gloria St John – ISBN 0–8135 – 2520- 9.Google Scholar
  5. Indian Association of Palliative Care –
  6. Institute of Palliative Medicine and WHO Collaborating Centre for Community participation in Palliative care and long term care –
  7. International Association for Hospice and Palliative Care [IAHPC] –
  8. Introduction to Palliative Care – Robert Twycross.Google Scholar
  9. Journal of Community and supportive Oncology –
  10. National Gold Standards Framework Centre (GSF) in End of Life Care –
  11. Pallium India – WHO collaboration centre for training and access to pain relief –
  12. The Journey through Cancer – Dr Jeremy Geffen ISBN 0–609 – 60450 – 3.Google Scholar
  13. WHO Guidelines for Paediatric Pain relief –
  14. World Health Organisation’s Resolution during the 67th Assembly – Geneva Strengthening of palliative care as a component of comprehensive care throughout the life course

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Trivandrum Institute of Palliative Sciences -the WHO Collaborating Centre for Training and Policy on access to Pain ReliefTrivandrumIndia
  2. 2.Academic and Strategy ConsultantIndo American Cancer AssociationHoustonUSA
  3. 3.Department of Palliative MedicineTata Memorial HospitalMumbaiIndia
  4. 4.Editor - Indian Journal of Palliative MedicineTata Memorial HospitalMumbaiIndia

Personalised recommendations